| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |